entertainment -WSS

entertainment

author：explore 2025-09-09 19:28:59 - browse：1919

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Wikipedia

focus

WSS

An inside look at PIPEs, biotech's buzzy new financing tool

As Maui death toll rises, number of missing remains unclear

FogPharma raises $145 million in rare Series E round

Listen: Racing for gene therapy & a pioneering approval

Trump cancels press conference intended to dispute Georgia election interference charges

Listen: Racing for gene therapy & a pioneering approval

hotspot

entertainment

Sign up for D.C. Diagnosis

leisure time

In age of alternative facts, a scholarly course on calling out crap

Biotech companies concerned about China biosecurity crackdown

How to save PrEP access — and even expand it

International team creates first chimeric human

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Beware the threat of staffing cuts at the CDC

In Memoriam: Notable people who died in 2023

Congress must give Medicare recipients genetic counseling access

DIEP, the 'gold standard' of breast reconstruction, is under threat

A Q&A with Aletha Maybank, AMA’s chief health equity officer

entertainment

ActiGraph execs on goal of drug approvals with digital endpoints

Lung cancer is America's deadliest cancer. Yet so few get screened

Majority of Americans think Trump's Ga. election interference case is serious: POLL

International team creates first chimeric human

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Scientists unlock the key to scar

Wikipedia

focus

hotspot

focus